Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

doi:10.3109/14767050903301017

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians - 1 Aug 2010

Mazaki-Tovi Shali, Romero Roberto, Kim Sun Kwon, Vaisbuch Edi, Kusanovic Juan Pedro, Erez Offer, Chaiworapongsa Tinnakorn, Gotsch Francesca, Mittal Pooja, Nhan-Chang Chia-Ling, Than Nandor Gabor, Gomez Ricardo, Nien Jyh Kae, Edwin Samuel S, Pacora Percy, Yeo Lami, Hassan Sonia S

Abstract excerpt

OBJECTIVE: Women with preeclampsia and those who delivered a small-for-gestational-age (SGA) neonate share several mechanisms of disease, including chronic uteroplacental ischemia and failure of physiologic transformation of the spiral arteries. However, the clinical manifestation of these obstet...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Fetal Growth Retardation

Share to Infant, Newborn

Share to Infant, Small for Gestational Age

Share to Nicotinamide Phosphoribosyltransferase

Share to Pre-Eclampsia

Share to Pregnancy

Source

Open in PubMed Open full text

Identifiers

PMID: 19900033
DOI: 10.3109/14767050903301017
PMCID: PMC3554253

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19900033-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?PMID 19900033Read ↗

Preeclampsia: The Role of Angiogenic Factors in Its PathogenesisSemantic proximity Read ↗

Adipokines in preeclampsia: disrupted signaling pathways and novel therapeutic strategiesSemantic proximity Read ↗

Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.Semantic proximity Read ↗

Fetal Growth Restriction: Mechanisms, Epidemiology, and ManagementSemantic proximity Read ↗

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of PregnancySemantic proximity Read ↗

The Update of Fetal Growth Restriction Associated with BiomarkersSemantic proximity Read ↗

Preeclampsia As Modulator of Offspring Health1Semantic proximity Read ↗

First-trimester screening with specific algorithms for early- and late-onset fetal growth restrictionSemantic proximity Read ↗

miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth RestrictionSemantic proximity Read ↗

Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth RestrictionSemantic proximity Read ↗

Redefining Preeclampsia Using Placenta-Derived BiomarkersSemantic proximity Read ↗

Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.